Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions.

"Disclosure of potential conflict of interest: M. Ehlers received grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—grant numbers 257739680 (EH 221/8-1), 398859914 (EH 221/10-1), 222374435 (international iRTG 1911), 49701054 (Germany’s Excellence Strategies - EXC 306) and 390884018 (EXC 2167, Precision Medicine in Chronic Inflammation [PMI])—and the Volkswagenstiftung (grant no. 97301) for this work and grants from the DFG—grant numbers 400912066 (EH 221/11-1), 269234613 (Clinical Research Unit 303, EH 221/9-1), 179309734 (RTG 1727)—and the Else Kroener-Fresenius-Foundation (2014_A91) for other works; and is employed by the University of Lüubeck. A. Leliavski received junior grants from the University of Lüubeck, and the EXC 306 for other works. The rest of the authors declare that they have no relevant conflicts of interest."

"M.E. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—grant numbers 257739680 (EH 221/8-1), 398859914 (EH 221/10-1), 222374435 (international Research Training Group - iRTG 1911), 49701054 (Germany’s Excellence Strategies - EXC 306) and 390884018 (EXC 2167, Precision Medicine in Chronic Inflammation [PMI])—and the VolkswagenStiftung (grant no. 97301). A.L. received junior grants from the University of Lüubeck and the EXC 306. Y.C.B. and H.B.L. were members and J.P., L.D., S.L., and G.-M.L. were associated members of the RTG 1727. A.E. and J.R. were members of the iRTG 1911. Disclosure of potential conflict of interest: M. Ehlers received grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—grant numbers 257739680 (EH 221/8-1), 398859914 (EH 221/10-1), 222374435 (international iRTG 1911), 49701054 (Germany’s Excellence Strategies - EXC 306) and 390884018 (EXC 2167, Precision Medicine in Chronic Inflammation [PMI])—and the Volkswagenstiftung (grant no. 97301) for this work and grants from the DFG—grant numbers 400912066 (EH 221/11-1), 269234613 (Clinical Research Unit 303, EH 221/9-1), 179309734 (RTG 1727)—and the Else Kroener-Fresenius-Foundation (2014_A91) for other works; and is employed by the University of Lüubeck. A. Leliavski received junior grants from the University of Lüubeck, and the EXC 306 for other works. The rest of the authors declare that they have no relevant conflicts of interest."